Durvalumab 17228-4611
Product NDC
17228-4611- Manufacturer
- Astrazeneca Ab
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- January 1, 2020
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Durvalumab | 500 mg/10mL |
Packaging Options(2)
330 VIAL in 1 TRAY (17228-4611-5) / 10 mL in 1 VIAL
330 VIAL in 1 TRAY (17228-4611-6) / 10 mL in 1 VIAL